Nystatin
Classification: BATC code: A07AA02
Summary
Published controlled studies on differences between men and women in effect, safety and pharmacokinetics of nystatin are lacking.
Additional information
Pharmacokinetics and dosing
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of nystatin have been found.
Effects
No studies with a clinically relevant sex analysis regarding the effects of nystatin have been found.
Adverse effects
No studies with a clinically relevant sex analysis regarding adverse effects of nystatin have been found.
Reproductive health issues
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Other information
In some countries, nystatin is available as vaginal preparations. They may damage latex contraceptives and thus additional contraceptives may be needed [1].
Updated: 2020-08-28
Date of litterature search: 2015-06-02
References
- Martindale: The Complete Drug Reference. Pharmaceutical Press.
- Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-04-05.] länk
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson